Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Ming He

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|October 22, 2020
Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK BiobankMing-Ming He, Zhe Fang, Dong Hang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 2, 2015
The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinomaXiao-Li Wei, Dong-Sheng Zhang, Ming-Ming He, et al.
Annals of Translational Medicine|January 14, 2020
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkersHao-Xiang Wu, Zi-Xian Wang, Qi Zhao, et al.
Mayo Clinic Proceedings|July 9, 2023
In Utero and Childhood/Adolescence Exposure to Tobacco Smoke, Genetic Risk, and Cancer Incidence in Adulthood: A Prospective Cohort StudyHeng He, Qian Shen, Ming-Ming He, et al.
Oncotarget|April 15, 2015
microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancerDong-liang Chen, Dong-sheng Zhang, Yun-xin Lu, et al.
JAMA Network Open|May 4, 2019
Correlation of Milestone Restricted Mean Survival Time Ratio With Overall Survival Hazard Ratio in Randomized Clinical Trials of Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisZi-Xian Wang, Hao-Xiang Wu, Li Xie, et al.
Cancer Management and Research|May 24, 2019
A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patientsLu-Ping Yang, Zi-Xian Wang, Ming-Ming He, et al.
Eclinicalmedicine|May 28, 2026
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 studyMiao-Zhen Qiu, Keun-Wook Lee, Markus Möhler, et al.
Cancer|February 6, 2024
Post-diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort studyMing-Ming He, Kai Wang, Chun-Han Lo, et al.
Experimental & Molecular Medicine|June 27, 2022
LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcriptionXiao-Jing Luo, Ming-Ming He, Jia Liu, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|October 22, 2020
Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK BiobankMing-Ming He, Zhe Fang, Dong Hang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 2, 2015
The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinomaXiao-Li Wei, Dong-Sheng Zhang, Ming-Ming He, et al.
Annals of Translational Medicine|January 14, 2020
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkersHao-Xiang Wu, Zi-Xian Wang, Qi Zhao, et al.
Mayo Clinic Proceedings|July 9, 2023
In Utero and Childhood/Adolescence Exposure to Tobacco Smoke, Genetic Risk, and Cancer Incidence in Adulthood: A Prospective Cohort StudyHeng He, Qian Shen, Ming-Ming He, et al.
Oncotarget|April 15, 2015
microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancerDong-liang Chen, Dong-sheng Zhang, Yun-xin Lu, et al.
JAMA Network Open|May 4, 2019
Correlation of Milestone Restricted Mean Survival Time Ratio With Overall Survival Hazard Ratio in Randomized Clinical Trials of Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisZi-Xian Wang, Hao-Xiang Wu, Li Xie, et al.
Cancer Management and Research|May 24, 2019
A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patientsLu-Ping Yang, Zi-Xian Wang, Ming-Ming He, et al.
Eclinicalmedicine|May 28, 2026
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 studyMiao-Zhen Qiu, Keun-Wook Lee, Markus Möhler, et al.
Cancer|February 6, 2024
Post-diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort studyMing-Ming He, Kai Wang, Chun-Han Lo, et al.
Experimental & Molecular Medicine|June 27, 2022
LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcriptionXiao-Jing Luo, Ming-Ming He, Jia Liu, et al.
Pageof 5